1. Home
  2. |Insights
  3. |The UPC’s New Case Management System—What to Know

The UPC’s New Case Management System—What to Know

What You Need to Know

  • Key takeaway #1

    The UPC has introduced the first phase of a new case management system.

  • Key takeaway #2

    The new system shows that the UPC is committed to improving its services and its attractiveness as a venue for patent litigation in Europe.

Client Alert | 07.08.25

For the past few years since its official launch, as well as getting to grips with the developing procedures and case law of the Unified Patent Court (UPC), representatives have been using the UPC’s Case Management System (CMS) in its first iteration.

The new UPC CMS launched today, for opt-out procedures only, with infringement, validity, and other procedures to be added in the coming months.

At Crowell, we have participated in the initial trialing of the system, to get a feel for the improved site, and also to ensure that we are fully prepared for the switchover for opt-outs. The system is modernized, intuitive and smooth, and we expect this change will be very pleasing to frequent users of the UPC systems, and anyone in the (admittedly niche) category of litigation website enthusiasts.

In the meantime, the existing CMS will continue to be available, for procedures not yet available in the new CMS.

Smartcards will not be needed for accessing the new UPC CMS, with the UPC moving to align its login procedures more closely with the EPO’s online filing and case management services. However, before celebrating this simplification, representatives should note that there is no change to the requirements for certifying uploaded documents, meaning that in many cases you may still need to use a smart card for signing a document, before uploading the document to the new CMS.

As much as the new CMS web interface is pleasant to look at, API automation for individual or bulk opt-outs was already a smooth process, and the API will continue to be the most convenient and reliable strategy available for filing opt-outs for many users.

Nevertheless, opt-outs will be just one function of the revamped CMS, and we look forward to using the new CMS for centralized infringement and revocation actions covering much of Europe.

Learn more about our Crowell & Moring London Team here.

Thank you to Crowell counsel James Prankerd Smith for his contributions to this alert.

Contacts

Insights

Client Alert | 5 min read | 12.12.25

Eleventh Circuit Hears Argument on False Claims Act Qui Tam Constitutionality

On the morning of December 12, 2025, the Eleventh Circuit heard argument in United States ex rel. Zafirov v. Florida Medical Associates, LLC, et al., No. 24-13581 (11th Cir. 2025). This case concerns the constitutionality of the False Claims Act (FCA) qui tam provisions and a groundbreaking September 2024 opinion in which the United States District Court for the Middle District of Florida held that the FCA’s qui tam provisions were unconstitutional under Article II. See United States ex rel. Zafirov v. Fla. Med. Assocs., LLC, 751 F. Supp. 3d 1293 (M.D. Fla. 2024). That decision, penned by District Judge Kathryn Kimball Mizelle, was the first success story for a legal theory that has been gaining steam ever since Justices Thomas, Barrett, and Kavanaugh indicated they would be willing to consider arguments about the constitutionality of the qui tam provisions in U.S. ex rel. Polansky v. Exec. Health Res., 599 U.S. 419 (2023). In her opinion, Judge Mizelle held (1) qui tam relators are officers of the U.S. who must be appointed under the Appointments Clause; and (2) historical practice treating qui tam and similar relators as less than “officers” for constitutional purposes was not enough to save the qui tam provisions from the fundamental Article II infirmity the court identified. That ruling was appealed and, after full briefing, including by the government and a bevy of amici, the litigants stepped up to the plate this morning for oral argument....

View All Insights